Atrial fibrillation (AF) remains a major clinical challenge in Europe, with ongoing needs for greater precision, safety, and long-term durability in ablation. The recent CE Mark approval of the TactiFlex™ Duo Ablation Catheter, combining high-resolution mapping with emerging pulsed-field ablation (PFA) technology, offers a new option to help address these gaps. Dr John Silberbauer explores how the device may enhance AF treatment, reviews the supporting clinical evidence, and considers what this milestone means for physicians and patients across Europe.

We are pleased to announce the appointment of Dr Andreas Boehmer to the Heart International Editorial Board. Dr Boehmer is an Electrophysiology Fellow at St. Josefs-Hospital Wiesbaden in Germany, where he works within the Department of Cardiology and conducts research focused on interventional therapies for cardiac arrhythmias and the treatment of patients with tachycardiomyopathy.

We are delighted to welcome Dr Sushant Saluja, NIHR Clinical Lecturer in Cardiology at the University of Manchester, to our Editorial Board. Dr Saluja brings a distinguished record in interventional cardiology, population genetics and precision medicine, with research published in leading journals including Nature Genetics, Nature Communications, European Heart Journal and the Journal of Hypertension.

Cardiovascular medicine in 2025 has been marked by rapid innovation and meaningful shifts in clinical practice. In this year-in-review, touchCARDIO brings together expert reflections highlighting paradigm-changing trial data, the emergence of pulsed field ablation and conduction system pacing, advances in imaging and prevention, and the accelerating integration of artificial intelligence. Collectively, these perspectives underscore a field evolving toward more precise, technology-enabled and preventive cardiovascular care, while emphasising the need to translate scientific progress into improved outcomes for patients worldwide.

As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchCARDIO. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the cardiology community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.

In this Q&A, Dr Camm shares his thoughts on how meaningful impacts can be made by early career cardiologists, the possibility of artificial intelligence (AI) for the future of cardiology and the entirety of medicine, and his hopes for the future.

July 2025 marked continued progress in cardiovascular innovation, with notable regulatory decisions and clinical trial milestones. Approvals, designations, and data readouts during the month highlight the field’s ongoing shift toward targeted therapies, gene-based interventions, and outcome-driven evidence. These developments reflect growing momentum in addressing complex and underserved cardiovascular conditions.

We are delighted to introduce touchCARDIO Future Leader 2025, Dr Jenna Spears, currently in her final year of electrophysiology fellowship training at the Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Originally from Oakville, Ontario, Dr Spears completed her medical ...

Today, NICE recommended pulsed field ablation (PFA) for the treatment of atrial fibrillation (AF), the most common heart rhythm disorder, affecting around 2% of UK adults.